Prosecution Insights
Last updated: July 05, 2026
Application No. 17/798,869

USE OF ALIPHATIC ISOCYANATE AS TOXIC FUME SUPRESSANT IN POLYURETHANE FOAMS

Non-Final OA §102
Filed
Aug 10, 2022
Priority
Feb 10, 2020 — EU 20382085.7 +1 more
Examiner
RIOJA, MELISSA A
Art Unit
1764
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Indresmat BV
OA Round
3 (Non-Final)
50%
Grant Probability
Moderate
3-4
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 50% of resolved cases
50%
Career Allowance Rate
428 granted / 861 resolved
-15.3% vs TC avg
Strong +54% interview lift
Without
With
+54.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
48 currently pending
Career history
925
Total Applications
across all art units

Statute-Specific Performance

§101
0.4%
-39.6% vs TC avg
§103
64.8%
+24.8% vs TC avg
§102
6.7%
-33.3% vs TC avg
§112
13.5%
-26.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 861 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on February 6, 2026 has been entered. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1, 4, and 5 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by US 4,026,829 to Samura et al. (hereinafter Samura). Regarding Claims 1, 4, and 5. Samura teaches a method comprising: a step in which a polyurethane foam undergoes flame contact (Column 3, Lines firefire64 – 66), i.e. a step of exposing a polyurethane foam to fire. Samura further teaches the polyurethane foam has flame retardant properties (Column 3, Lines 65 – 67), corresponding to a step of retarding a flame in the polyurethane foam. An isocyanate is included in the polyurethane foam by reacting with a polyetherpolyol (Column 1, Lines 57 – 68), i.e. at least one polyol compound. The isocyanate may be 1,6-hexamethylene diisocyanate or isophorone diisocyanate (Column 3, Lines 9 – 15), which are each set forth as one aliphatic diisocyanate compound in instant Claim 5. Samura teaches fire proofing additives, i.e. flame retardants, are optional additives in the polyurethane foam (Column 3, Lines 42 – 43). Thus, embodiments in which the polyurethane foam has an absence of added flame retardants would be readily envisioned from the reference. Samura does teach the inventive polyurethane foam has a reduced amount of smoke (Column 3, Lines 64 – 66), though the reference does not expressly teach inclusion of the aliphatic isocyanate component by reaction with the at least one polyol compound has the effects of suppressing a toxic fume. However, it has been held that, where the claimed and prior art products are identical or substantially identical in structure or composition, or are produced by identical or substantially identical processes, a prima facie case of either anticipation or obviousness has been established. In re Best, 562 F.2d 1252, 1255, 195 USPQ 430, 433 (CCPA 1977) Moreover, products of identical chemical composition cannot have mutually exclusive properties." In re Spada, 911 F.2d 705, 709, 15 USPQ2d 1655, 1658. Samura’s foam is produced by an identical process to that claimed and thereby forms a polyurethane foam product which is identical in chemical composition to the claimed polyurethane foam. Thus, the method of Samura a must necessarily have the same effects as the instantly claimed method of suppressing a toxic fume. Response to Arguments Applicant’s arguments, see Pages 4 – 6, filed February 6, 2026, with respect to the rejection of the instant claims under 35 U.S.C. 102(a)(1) as being anticipated by JP 2001316445 to Katsumata have been fully considered and are persuasive. Therefore, the rejection has been withdrawn. However, upon further consideration, a new ground of rejection under 35 U.S.C. 102(a)(1) is made in view of US 4,026,829 to Samura et al. Correspondence Any inquiry concerning this communication or earlier communications from the examiner should be directed to MELISSA RIOJA whose telephone number is (571)270-3305. The examiner can normally be reached Monday - Friday 10:00 am - 6:30 pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Arrie Lanee Reuther can be reached at (571)270-7026. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MELISSA A RIOJA/ Primary Examiner, Art Unit 1764
Read full office action

Prosecution Timeline

Aug 10, 2022
Application Filed
Feb 05, 2025
Non-Final Rejection mailed — §102
Jun 05, 2025
Response Filed
Aug 06, 2025
Final Rejection mailed — §102
Nov 06, 2025
Response after Non-Final Action
Feb 06, 2026
Request for Continued Examination
Feb 09, 2026
Response after Non-Final Action
Apr 01, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12662566
POLYURETHANE FOAM AND METHODS OF FORMING THE SAME
3y 5m to grant Granted Jun 23, 2026
Patent 12654280
CMP PAD HAVING POLISHING LAYER OF LOW SPECIFIC GRAVITY
4y 0m to grant Granted Jun 16, 2026
Patent 12649809
FOAMS AND METHODS OF FORMING FOAMS OF CHAIN EXTENDED/BRANCHED COPOLYMERS OF VINYLIDENE SUBSTITUTED AROMATIC MONOMERS
5y 0m to grant Granted Jun 09, 2026
Patent 12643976
ISOCYANATE-TERMINATED PREPOLYMERS BASED ON POLYOXYMETHYLENE-POLYOXYALKYLENE BLOCK COPOLYMERS, PROCESS FOR THE PREPARATION AND USE THEREOF
3y 3m to grant Granted Jun 02, 2026
Patent 12630684
Article with Crosslinked Foam Layer Adhered to Substrate
3y 5m to grant Granted May 19, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
50%
Grant Probability
99%
With Interview (+54.0%)
3y 1m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 861 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month